Coronavirus: Alarm at German AstraZeneca pause as cases spike

Emer Cooke, executive director of the European Medicines Agency, said the EMA was still “firmly convinced” of the benefits of the AstraZeneca drug, and she pointed out that blood clots highlighted by some countries were relatively common in the general population. The main question was whether it was a real side-effect of the vaccine or a coincidence, she said.

Leave a Reply